Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lonza
Pharma
Lonza hints at CDMO rebound as it reaffirms 2024 guidance
With a new CEO waiting in the wings, Lonza is attempting to reassure the market that a CDMO industry stabilization is playing out.
Fraiser Kansteiner
May 14, 2024 10:22am
Lonza poaches Siegfried's Wolfgang Wienand as new CEO
Apr 2, 2024 11:06am
Abzena earmarks $5M to bolster ADC services at Pennsylvania site
Mar 28, 2024 8:40am
Lonza strikes $1.2B deal to buy mammoth Roche plant
Mar 20, 2024 11:33am
Takeda, Lonza, US legislation—Fierce Pharma Asia
Feb 2, 2024 8:15am
Lonza closes plant in China but has a turnaround quarter
Jan 26, 2024 3:11pm